2024 Q2 Form 10-Q Financial Statement

#000115916724000039 Filed on May 08, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q2
Revenue $166.4M $150.0M $160.3M
YoY Change 3.79% -45.1%
Cost Of Revenue $138.9M $113.9M $123.7M
YoY Change 12.25% -32.91%
Gross Profit $27.47M $36.10M $36.55M
YoY Change -24.86% -66.0%
Gross Profit Margin 16.51% 24.07% 22.8%
Selling, General & Admin $56.91M -$24.00M $75.74M
YoY Change -24.86% -13.7%
% of Gross Profit 207.19% -66.47% 207.21%
Research & Development $23.23M $33.88M $41.93M
YoY Change -44.6% -1.4%
% of Gross Profit 84.58% 93.84% 114.73%
Depreciation & Amortization $5.304M $5.812M $7.542M
YoY Change -29.67% -32.91%
% of Gross Profit 19.31% 16.1% 20.63%
Operating Expenses $88.53M $24.20M $117.8M
YoY Change -24.87% -9.9%
Operating Profit -$61.07M $11.90M -$81.30M
YoY Change -24.89% 249.12%
Interest Expense $5.400M $5.500M $0.00
YoY Change -100.0%
% of Operating Profit 46.22%
Other Income/Expense, Net -$8.849M -$3.185M -$1.077M
YoY Change 721.63% -93.57%
Pretax Income -$69.92M $8.715M -$82.37M
YoY Change -15.12% 105.77%
Income Tax $700.0K $100.0K -$1.300M
% Of Pretax Income 1.15%
Net Earnings -$70.65M $8.607M -$81.11M
YoY Change -12.9% 166.76%
Net Earnings / Revenue -42.47% 5.74% -50.6%
Basic Earnings Per Share -$2.41 $0.31 -$2.95
Diluted Earnings Per Share -$2.41 $0.30 -$2.95
COMMON SHARES
Basic Shares Outstanding 28.76M shares 27.96M shares 27.47M shares
Diluted Shares Outstanding 29.31M shares 28.27M shares 27.47M shares

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $108.5M $118.4M $47.92M
YoY Change 126.47% -57.78%
Cash & Equivalents $108.5M $118.4M $47.90M
Short-Term Investments
Other Short-Term Assets $21.56M $40.86M $56.99M
YoY Change -62.17% -41.1%
Inventory $101.4M $133.3M $229.7M
Prepaid Expenses
Receivables $68.13M $39.32M $29.65M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $340.1M $371.9M $364.2M
YoY Change -6.62% -43.7%
LONG-TERM ASSETS
Property, Plant & Equipment $29.46M $34.33M $55.77M
YoY Change -47.18% -22.4%
Goodwill $169.4M $169.7M $169.6M
YoY Change -0.11% -0.23%
Intangibles $4.404M $4.682M $10.92M
YoY Change -59.67% -58.99%
Long-Term Investments $11.00M $11.00M $15.10M
YoY Change -27.15% -1.31%
Other Assets $17.38M $18.64M $23.46M
YoY Change -25.94% -39.59%
Total Long-Term Assets $245.8M $254.3M $300.4M
YoY Change -18.16% -22.89%
TOTAL ASSETS
Total Short-Term Assets $340.1M $371.9M $364.2M
Total Long-Term Assets $245.8M $254.3M $300.4M
Total Assets $585.9M $626.1M $664.6M
YoY Change -11.84% -35.88%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $113.6M $103.2M $74.01M
YoY Change 53.43% -57.19%
Accrued Expenses $96.94M $93.84M $100.9M
YoY Change -3.93% 12.89%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $27.00M
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $221.6M $207.4M $214.0M
YoY Change 3.57% -22.35%
LONG-TERM LIABILITIES
Long-Term Debt $172.4M $168.6M $0.00
YoY Change
Other Long-Term Liabilities $18.76M $19.80M $23.08M
YoY Change -18.71% -9.78%
Total Long-Term Liabilities $215.2M $214.7M $55.19M
YoY Change 289.97% -15.97%
TOTAL LIABILITIES
Total Short-Term Liabilities $221.6M $207.4M $214.0M
Total Long-Term Liabilities $215.2M $214.7M $55.19M
Total Liabilities $436.9M $422.1M $269.2M
YoY Change 62.29% -21.12%
SHAREHOLDERS EQUITY
Retained Earnings -$167.3M -$96.69M $118.3M
YoY Change -241.45% -74.02%
Common Stock $320.0M $302.0M $264.1M
YoY Change 21.15% 15.13%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $149.1M $204.1M $395.4M
YoY Change
Total Liabilities & Shareholders Equity $585.9M $626.1M $664.6M
YoY Change -11.84% -35.88%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q2
OPERATING ACTIVITIES
Net Income -$70.65M $8.607M -$81.11M
YoY Change -12.9% 166.76%
Depreciation, Depletion And Amortization $5.304M $5.812M $7.542M
YoY Change -29.67% -32.91%
Cash From Operating Activities -$21.67M $1.400M -$94.50M
YoY Change -77.07% -7.64%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $118.0K $1.456M
YoY Change -100.0% -53.23%
Acquisitions
YoY Change
Other Investing Activities -$46.00K $0.00 $73.00K
YoY Change -163.01% -85.4%
Cash From Investing Activities -$46.00K -$118.0K -$1.529M
YoY Change -96.99% -112.13%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $34.95M $0.00
YoY Change
Cash From Financing Activities 12.00M -$29.94M $25.41M
YoY Change -52.78% -3595.05%
NET CHANGE
Cash From Operating Activities -21.67M $1.400M -$94.50M
Cash From Investing Activities -46.00K -$118.0K -$1.529M
Cash From Financing Activities 12.00M -$29.94M $25.41M
Net Change In Cash -9.717M -$27.74M -$70.03M
YoY Change -86.13% -21.68%
FREE CASH FLOW
Cash From Operating Activities -$21.67M $1.400M -$94.50M
Capital Expenditures $0.00 $118.0K $1.456M
Free Cash Flow -$21.67M $1.282M -$95.96M
YoY Change -77.42% -8.98%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 irbt Costofproductrevenue
Costofproductrevenue
113913000 usd
CY2023Q2 irbt Costofproductrevenue
Costofproductrevenue
123269000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
8607000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7932000 usd
CY2023Q2 irbt Stock Withheld To Cover Tax Withholding Requirements Upon Vesting To Restricted Stock Units Amount
StockWithheldToCoverTaxWithholdingRequirementsUponVestingToRestrictedStockUnitsAmount
1600000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-5506000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
8607000 usd
CY2024Q1 us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
0 usd
CY2023Q2 us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
282000 usd
CY2024Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
113913000 usd
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
123551000 usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
36101000 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
36741000 usd
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
33878000 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
41269000 usd
CY2024Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
29716000 usd
CY2023Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
42476000 usd
CY2024Q1 irbt General And Administrative Expense Net
GeneralAndAdministrativeExpenseNet
-53711000 usd
CY2023Q2 irbt General And Administrative Expense Net
GeneralAndAdministrativeExpenseNet
30310000 usd
CY2024Q1 us-gaap Restructuring Charges
RestructuringCharges
14146000 usd
CY2023Q2 us-gaap Restructuring Charges
RestructuringCharges
3805000 usd
CY2024Q1 irbt Amortizationof Intangible Assets Nonproduction
AmortizationofIntangibleAssetsNonproduction
172000 usd
CY2023Q2 irbt Amortizationof Intangible Assets Nonproduction
AmortizationofIntangibleAssetsNonproduction
178000 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
24201000 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
118038000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
11900000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-81297000 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3185000 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1077000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
8715000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-82374000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
108000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1262000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
8607000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-81112000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.31
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.95
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.30
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.95
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28171000 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27467000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28266000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27467000 shares
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
8607000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-81112000 usd
CY2024Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
-7226000 usd
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
1720000 usd
CY2024Q1 irbt Other Comprehensive Income Loss Cash Flow Hedge Unrealized Gain Loss Net Of Tax
OtherComprehensiveIncomeLossCashFlowHedgeUnrealizedGainLossNetOfTax
3213000 usd
CY2023Q2 irbt Other Comprehensive Income Loss Cash Flow Hedge Unrealized Gain Loss Net Of Tax
OtherComprehensiveIncomeLossCashFlowHedgeUnrealizedGainLossNetOfTax
-1823000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
4886000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
5403000 usd
CY2024Q1 irbt Other Comprehensive Income Loss Change In Fair Value Of Term Loan
OtherComprehensiveIncomeLossChangeInFairValueOfTermLoan
-3089000 usd
CY2023Q2 irbt Proceeds From Issuance Of Common Stock Net Of Issuance Costs
ProceedsFromIssuanceOfCommonStockNetOfIssuanceCosts
0 usd
CY2023Q2 irbt Other Comprehensive Income Loss Change In Fair Value Of Term Loan
OtherComprehensiveIncomeLossChangeInFairValueOfTermLoan
0 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3381000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-86618000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
196487000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7948000 usd
CY2024Q1 irbt Share Based Payment Arrangement Ceo Transition Costs Related To Stock Based Awards
ShareBasedPaymentArrangementCEOTransitionCostsRelatedToStockBasedAwards
2227000 usd
CY2024Q1 irbt Stock Withheld To Cover Tax Withholding Requirements Upon Vesting To Restricted Stock Units Amount
StockWithheldToCoverTaxWithholdingRequirementsUponVestingToRestrictedStockUnitsAmount
390000 usd
CY2024Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
5632000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-11988000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
204069000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
475716000 usd
CY2023Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
9000 shares
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-5506000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-81112000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
395439000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-81112000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5812000 usd
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7542000 usd
CY2024Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
-375000 usd
CY2023Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
0 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
7948000 usd
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
7932000 usd
CY2024Q1 irbt Debt Instrument Changes In Fair Value
DebtInstrumentChangesInFairValue
-1008000 usd
CY2023Q2 irbt Debt Instrument Changes In Fair Value
DebtInstrumentChangesInFairValue
0 usd
CY2024Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
239000 usd
CY2023Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
0 usd
CY2024Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
127000 usd
CY2023Q2 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-647000 usd
CY2024Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
3452000 usd
CY2023Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
3562000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-38565000 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-37147000 usd
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-16266000 usd
CY2023Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-52947000 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-6045000 usd
CY2023Q2 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-53000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-74601000 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-109930000 usd
CY2024Q1 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-3232000 usd
CY2023Q2 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-6171000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1437000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-94507000 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
118000 usd
CY2023Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1456000 usd
CY2024Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0 usd
CY2023Q2 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
73000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-118000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1529000 usd
CY2024Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
0 usd
CY2023Q2 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
9000 usd
CY2024Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
390000 usd
CY2023Q2 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1600000 usd
CY2024Q1 irbt Proceeds From Issuance Of Common Stock Net Of Issuance Costs
ProceedsFromIssuanceOfCommonStockNetOfIssuanceCosts
5632000 usd
CY2024Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 usd
CY2023Q2 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
27000000 usd
CY2024Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
34947000 usd
CY2023Q2 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 usd
CY2024Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
239000 usd
CY2023Q2 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-29944000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
25409000 usd
CY2024Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
882000 usd
CY2023Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
593000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-27743000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-70034000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
187887000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
117949000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
160144000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
47915000 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
118356000 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
47915000 usd
CY2024Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
40012000 usd
CY2023Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
0 usd
CY2024Q1 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1776000 usd
CY2023Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
0 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
160144000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
47915000 usd
CY2024Q1 us-gaap Nature Of Operations
NatureOfOperations
Nature of the Business<div style="margin-top:5pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iRobot Corporation ("iRobot" or the "Company") designs, builds and sells robots and home innovations that make life better. The Company's portfolio of home robots and smart home devices features proprietary technologies for the connected home and advanced concepts in cleaning, mapping and navigation, human-robot interaction and physical solutions. iRobot's durable and high-performing robots are designed using the close integration of software, electronics and hardware. The Company's revenue is primarily generated from product sales through a variety of distribution channels, including chain stores and other national retailers, through the Company's own website and app, dedicated e-commerce websites, the online arms of traditional retailers and through value-added distributors and resellers worldwide.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Termination of Merger Agreement</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As previously disclosed, on August 4, 2022, the Company entered into an Agreement and Plan of Merger (the "Original Merger Agreement") with Amazon.com, Inc., a Delaware corporation ("Parent" or "Amazon"), and Martin Merger Sub, Inc., a Delaware corporation and an indirect wholly owned subsidiary of Amazon ("Merger Sub"), providing for, among other things, the merger of Merger Sub with and into iRobot, with the Company surviving the merger as a wholly owned subsidiary of Parent (the "Merger", and, together with the other transactions contemplated by the Merger Agreement (as defined below), the "Transactions"). On July 24, 2023, iRobot, Amazon and Merger Sub entered into an amendment to the Original Merger Agreement (the "Amendment", and the Original Merger Agreement, as amended and supplemented by the Amendment, the "Merger Agreement"). The Amendment adjusted the merger consideration to reflect the incurrence of the Term Loan (see Note 9, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information).</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 28, 2024, the Company and Amazon mutually agreed to terminate the Merger Agreement and entered into a mutual termination agreement effective as of such date (the "Termination Agreement"). The termination of the Merger Agreement was approved by the Company's Board of Directors ("Board"). In accordance with the terms of the Termination Agreement, Amazon made a cash payment to the Company in the previously agreed amount of $94.0 million (the "Parent Termination Fee") on January 29, 2024. As a result of the termination of the Merger Agreement and receipt of the Parent Termination Fee of $94.0 million from Amazon, the Company made a payment of $18.8 million for professional fees incurred in connection with the Transactions. In accordance with the terms of the Credit Agreement (as defined below), the Company applied $35.0 million to repay a portion of the Term Loan. The remaining $40.0 million of the Parent Termination Fee was set aside as restricted cash to be used for future repayments of the Term Loan subject to limited rights of the Company to utilize such amounts for the purchase of inventory. See Note 9, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for additional information. The Parent Termination Fee received net of professional fees paid was $75.2 million and was recorded as a benefit in general and administrative expenses on the consolidated statements of operations.</span></div>
CY2024Q1 us-gaap Fiscal Period
FiscalPeriod
<div style="margin-bottom:5pt;margin-top:5pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates and reports using a 52-53 week fiscal year ending on the Saturday closest to December 31. Accordingly, the Company's fiscal quarters end on the Saturday that falls closest to the last day of the third month of each quarter.</span></div>
CY2024Q1 irbt Revenue Increase Decrease
RevenueIncreaseDecrease
-0.064
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
11900000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1400000 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
118400000 usd
CY2024Q1 us-gaap Restricted Cash
RestrictedCash
41800000 usd
CY2024Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
40000000 usd
CY2024Q1 us-gaap Restructuring And Related Cost Expected Number Of Positions Eliminated
RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated
350 employee
CY2023 irbt Restructuring And Related Cost Expected Number Of Positions Eliminated Period Percent
RestructuringAndRelatedCostExpectedNumberOfPositionsEliminatedPeriodPercent
0.31
irbt Number Of Sublease Agreements
NumberOfSubleaseAgreements
3 sublease_agreement
CY2024Q1 us-gaap Lessor Operating Lease Payments To Be Received
LessorOperatingLeasePaymentsToBeReceived
4000000 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
133300000 usd
CY2024Q1 irbt Days In Inventory
DaysInInventory
P107D
CY2024Q1 irbt Increase Decrease In Inventory Net
IncreaseDecreaseInInventoryNet
-19200000 usd
CY2024Q1 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
11000000 usd
CY2023Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
11400000 usd
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:5pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of these financial statements in conformity with GAAP requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and revenue and expenses. These estimates and judgments, include but are not limited to, revenue recognition, including variable consideration and other obligations such as sales incentives and product returns; impairment of goodwill and long-lived assets; valuation of non-marketable equity investments; valuation of debt; inventory excess and obsolescence; loss contingencies; and accounting for income taxes and related valuation allowances. The Company bases its estimates and assumptions on historical experience, market participant fair value considerations, projected future cash flows, current economic conditions, and various other factors that the Company believes are reasonable under the circumstances. Actual results and outcomes may differ from the Company's estimates and assumptions.</span></div>
CY2024Q1 us-gaap Restricted Cash
RestrictedCash
41800000 usd
CY2024Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
40000000 usd
CY2024Q1 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1800000 usd
CY2024Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
2700000 usd
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
2700000 usd
CY2024Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2024Q1 irbt Impairment Of Long Lived Assets
ImpairmentOfLongLivedAssets
0 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
8607000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-81112000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28171000 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27467000 shares
CY2024Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
95000 shares
CY2023Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28266000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27467000 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.31
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.95
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.30
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.95
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3000000 shares
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1000000 shares
CY2024Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
17000000 usd
CY2023Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
18400000 usd
CY2024Q1 irbt Refundliabilityproductreturns
Refundliabilityproductreturns
13400000 usd
CY2024Q1 irbt Refundliabilityothercreditsandincentives
Refundliabilityothercreditsandincentives
60500000 usd
CY2023Q4 irbt Refundliabilityproductreturns
Refundliabilityproductreturns
24600000 usd
CY2023Q4 irbt Refundliabilityothercreditsandincentives
Refundliabilityothercreditsandincentives
95300000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
150014000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
160292000 usd
CY2024Q1 us-gaap Contract With Customer Receivable After Allowance For Credit Loss
ContractWithCustomerReceivableAfterAllowanceForCreditLoss
36613000 usd
CY2023Q4 us-gaap Contract With Customer Receivable After Allowance For Credit Loss
ContractWithCustomerReceivableAfterAllowanceForCreditLoss
77112000 usd
CY2024Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
17549000 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
18702000 usd
CY2024Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
3400000 usd
CY2023Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
4200000 usd
CY2024Q1 us-gaap Restructuring Charges
RestructuringCharges
14100000 usd
CY2023Q2 us-gaap Restructuring Charges
RestructuringCharges
3800000 usd
CY2024Q1 irbt Restructuring And Related Cost To Be Settled In Cash
RestructuringAndRelatedCostToBeSettledInCash
14495000 usd
CY2023Q2 irbt Restructuring And Related Cost To Be Settled In Cash
RestructuringAndRelatedCostToBeSettledInCash
3805000 usd
CY2024Q1 irbt Restructuring And Related Cost Settled Without Cash
RestructuringAndRelatedCostSettledWithoutCash
-349000 usd
CY2023Q2 irbt Restructuring And Related Cost Settled Without Cash
RestructuringAndRelatedCostSettledWithoutCash
0 usd
CY2024Q1 us-gaap Restructuring Charges
RestructuringCharges
14146000 usd
CY2023Q2 us-gaap Restructuring Charges
RestructuringCharges
3805000 usd
CY2024Q1 us-gaap Restructuring And Related Cost Number Of Positions Eliminated
RestructuringAndRelatedCostNumberOfPositionsEliminated
330 employee
CY2024Q1 us-gaap Restructuring And Related Cost Expected Cost1
RestructuringAndRelatedCostExpectedCost1
15000000 usd
CY2024Q1 us-gaap Restructuring And Related Cost Cost Incurred To Date1
RestructuringAndRelatedCostCostIncurredToDate1
11300000 usd
CY2024Q1 us-gaap Restructuring Costs
RestructuringCosts
4600000 usd
CY2023Q4 us-gaap Restructuring Reserve
RestructuringReserve
0 usd
CY2024Q1 irbt Restructuring And Related Cost To Be Settled In Cash
RestructuringAndRelatedCostToBeSettledInCash
14495000 usd
CY2024Q1 us-gaap Payments For Restructuring
PaymentsForRestructuring
3673000 usd
CY2024Q1 us-gaap Restructuring Reserve
RestructuringReserve
10822000 usd
CY2024Q1 irbt Number Of Sublease Agreements
NumberOfSubleaseAgreements
3 sublease_agreement
CY2024Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0417
CY2024Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y8M26D
CY2024Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
1358000 usd
CY2023Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
1715000 usd
CY2024Q1 us-gaap Variable Lease Cost
VariableLeaseCost
1091000 usd
CY2023Q2 us-gaap Variable Lease Cost
VariableLeaseCost
825000 usd
CY2024Q1 us-gaap Sublease Income
SubleaseIncome
370000 usd
CY2023Q2 us-gaap Sublease Income
SubleaseIncome
44000 usd
CY2024Q1 us-gaap Lease Cost
LeaseCost
2079000 usd
CY2023Q2 us-gaap Lease Cost
LeaseCost
2496000 usd
CY2023Q4 us-gaap Accrued Employee Benefits Current And Noncurrent
AccruedEmployeeBenefitsCurrentAndNoncurrent
13593000 usd
CY2024Q1 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
9981000 usd
CY2023Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
1894000 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5081000 usd
CY2024Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
1708000 usd
CY2023Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
2008000 usd
CY2024Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
CY2023Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
4530000 usd
CY2024Q1 us-gaap Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year
LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear
831000 usd
CY2024Q1 irbt Lessee Operating Lease Liability Payments Net Of Sublease Income Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeRemainderOfFiscalYear
3699000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
6083000 usd
CY2024Q1 us-gaap Lessor Operating Lease Payments To Be Received Next Twelve Months
LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths
556000 usd
CY2024Q1 irbt Lessee Operating Lease Liability Payments Net Of Sublease Income Due Year One
LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearOne
5527000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
6049000 usd
CY2024Q1 us-gaap Lessor Operating Lease Payments To Be Received Two Years
LessorOperatingLeasePaymentsToBeReceivedTwoYears
572000 usd
CY2024Q1 irbt Lessee Operating Lease Liability Payments Net Of Sublease Income Due Year Two
LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearTwo
5477000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
5904000 usd
CY2024Q1 us-gaap Lessor Operating Lease Payments To Be Received Three Years
LessorOperatingLeasePaymentsToBeReceivedThreeYears
589000 usd
CY2024Q1 irbt Lessee Operating Lease Liability Payments Net Of Sublease Income Due Year Three
LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearThree
5315000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
5474000 usd
CY2024Q1 us-gaap Lessor Operating Lease Payments To Be Received Four Years
LessorOperatingLeasePaymentsToBeReceivedFourYears
607000 usd
CY2024Q1 irbt Lessee Operating Lease Liability Payments Net Of Sublease Income Due Year Four
LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueYearFour
4867000 usd
CY2024Q1 irbt Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
7574000 usd
CY2024Q1 irbt Lessor Operating Lease Payment To Be Received After Year Four
LessorOperatingLeasePaymentToBeReceivedAfterYearFour
840000 usd
CY2024Q1 irbt Lessee Operating Lease Liability Payments Net Of Sublease Income Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDueAfterYearFour
6734000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
35614000 usd
CY2024Q1 us-gaap Lessor Operating Lease Payments To Be Received
LessorOperatingLeasePaymentsToBeReceived
3995000 usd
CY2024Q1 irbt Lessee Operating Lease Liability Payments Net Of Sublease Income Due
LesseeOperatingLeaseLiabilityPaymentsNetOfSubleaseIncomeDue
31619000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
4278000 usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
31336000 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5081000 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
26255000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5216000 usd
CY2024Q1 irbt Accrued Manufacturing And Logistics Costs
AccruedManufacturingAndLogisticsCosts
4803000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
175105000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
5044000 usd
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
172000 usd
CY2024Q1 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-5365000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Foreign Currency Translation Gain Loss
FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss
-190000 usd
CY2024Q1 us-gaap Goodwill
Goodwill
169740000 usd
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4682000 usd
CY2024Q1 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
21608000 usd
CY2023Q4 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
24625000 usd
CY2024Q1 us-gaap Customer Refund Liability Current
CustomerRefundLiabilityCurrent
18381000 usd
CY2023Q4 us-gaap Customer Refund Liability Current
CustomerRefundLiabilityCurrent
12897000 usd
CY2024Q1 us-gaap Accrued Employee Benefits Current And Noncurrent
AccruedEmployeeBenefitsCurrentAndNoncurrent
15446000 usd
CY2023Q4 irbt Accrued Manufacturing And Logistics Costs
AccruedManufacturingAndLogisticsCosts
5462000 usd
CY2024Q1 irbt Accrued Interest Current
AccruedInterestCurrent
3806000 usd
CY2023Q4 irbt Accrued Interest Current
AccruedInterestCurrent
4498000 usd
CY2024Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
2698000 usd
CY2023Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
8927000 usd
CY2024Q1 irbt Accrued Merger And Related Liabilities Current
AccruedMergerAndRelatedLiabilitiesCurrent
2225000 usd
CY2023Q4 irbt Accrued Merger And Related Liabilities Current
AccruedMergerAndRelatedLiabilitiesCurrent
4721000 usd
CY2024Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
515000 usd
CY2023Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
7276000 usd
CY2024Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
9293000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
8890000 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
93837000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
97999000 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
5500000 usd
CY2024Q1 irbt Accrued Interest Current
AccruedInterestCurrent
3800000 usd
CY2024Q1 us-gaap Derivative Remaining Maturity1
DerivativeRemainingMaturity1
P3Y
CY2024Q1 us-gaap Revenues
Revenues
150014000 usd
CY2023Q2 us-gaap Revenues
Revenues
160292000 usd
CY2024Q1 irbt Payments For Contractual Obligations
PaymentsForContractualObligations
1500000 usd
CY2024Q1 irbt Excess Or Obsolete Costs From Commitments To Suppliers
ExcessOrObsoleteCostsFromCommitmentsToSuppliers
2800000 usd
CY2023Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
24625000 usd
CY2022Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
27379000 usd
CY2024Q1 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
3047000 usd
CY2023Q2 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
3477000 usd
CY2024Q1 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
6064000 usd
CY2023Q2 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
6238000 usd
CY2024Q1 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
21608000 usd
CY2023Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
24618000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
100000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1300000 usd
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.012
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.015
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001159167-24-000039-index-headers.html Edgar Link pending
0001159167-24-000039-index.html Edgar Link pending
0001159167-24-000039.txt Edgar Link pending
0001159167-24-000039-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
irbt-20240330.htm Edgar Link pending
irbt-20240330.xsd Edgar Link pending
irbtexhibit31133024.htm Edgar Link pending
irbtexhibit31233024.htm Edgar Link pending
irbtexhibit32133024.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
irbt-20240330_cal.xml Edgar Link unprocessable
irbt-20240330_def.xml Edgar Link unprocessable
irbt-20240330_lab.xml Edgar Link unprocessable
irbt-20240330_pre.xml Edgar Link unprocessable
irbt-20240330_htm.xml Edgar Link completed
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending